Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Nanjing Zengcheng Biomedical Technology Co. Ltd. operates within the Medical Devices & Mechanical Engineering technology area with a focused prosecution footprint. The company has 1 pending office action currently on record. This 1 action is being reviewed by 1 distinct examiner, centralizing the company's current interactions with the patent office. Such a concentrated approach allows for a specific focus on the individual merits of the pending application.
The prosecution is contained within 1 distinct art unit. GOOD, SAMANTHA M is the busiest examiner for the portfolio, holding 1 pending office action. This 1 action accounts for the total volume of 1 pending office action for the company. This alignment between the busiest examiner and the total pending actions indicates that all current Medical Devices & Mechanical Engineering prosecution is being handled by 1 examiner. This structure minimizes the complexity of managing multiple examiner relationships simultaneously.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GOOD, SAMANTHA M | 1 | 68.3% | +10.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18398371 | HIGH-INTEGRITY R-WAVE TRIGGERED TUMOR THERAPY APPARATUS | GOOD, SAMANTHA M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18398371 | HIGH-INTEGRITY R-WAVE TRIGGERED TUMOR THERAPY APPARATUS | GOOD, SAMANTHA M | — |
| Art Unit | Apps |
|---|---|
| 3794 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18398371 | HIGH-INTEGRITY R-WAVE TRIGGERED TUMOR THERAPY APPARATUS | GOOD, SAMANTHA M | 3794 | §103§112 | Non-Final OA | — | Pending | Dec 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNanjing Zengcheng Biomedical Technology Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Samantha M Good has the most, with 1 of Nanjing Zengcheng Biomedical Technology Co. Ltd.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
